References
- Jorizzo J., Sams W., Jegasothy B., Olansky A. Cimetidine as an immunomodulator: Chronic mucocutaneous candidiasis as a model. Ann. Int. Med. 1980; 92(Part 1)192–195, 1980
- Mekori Y., Bender E., Zapata-Sirvent R., Hansbrough J., Claman H. The effect of histamine receptor antagonists on specific and nonspecific suppression of experimental contact sensitivity. J. Allergy Clin. Immunol. 1985; 76: 90–96
- Palacios R., Alarcon-Segovia D. Cimetidine abrogates suppressor T cell function in vitro. Immunol. Letters 1981; 3: 33–37
- Lipsmeyer E. Effect of cimetidine on delayed hypersensitivity. Clin. Immunol. Immunopath 1980; 16: 166–172
- Peden N., Robertson A., Boyd E., Brown R., Gibbs J., Potts R., Wormsley K., Beck J. Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine. Gut 1982; 23: 398–403
- Talpaz M., Medina J., Patt Y., Goepfert H., Guillamondegui O., Wong W., Mavligit G. The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patients. Clin. Immunol. Immunopath. 1982; 24: 155–160
- Avella J., Binder H., Madsen J., Arkenase P. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet 1978; 1: 624–626
- White W., Ballow M. Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. NEJM 1985; 312: 198–202
- Jin Z., Kumar, Cleveland R., Murray D., Kaufman D. Inhibition of suppressor cell function by cimetidine in a murine model. Clin. Immunol. Immunopath. 1986; 38: 350–356
- Watson A., Dalbow M., Stachura I., Fragola J., Rubin M., Watson R., Bourke E. Immunologic studies in cimetidine-induced nephropathy and polymyositis. New Engl. J. Med. 1983; 308: 142–145
- Rocklin R., Breard J., Gupta S., Good R., Melmon K. Characterization of the human blood lymphocytes that produce a histamine- induced suppressor factor (HSF). Cell. Immunol. 1980; 51: 226–237
- Garovoy M., Reddish M., Rocklin R. Histamine-induced suppressor factor (HSF): Inhibition of helper T cell generation and function. J Immunol 1983; 130: 357–361
- Griswold D., Alessi S., Badger A., Poste G., Hanna N. Inhibtion of T suppressor cell expression by histamine Type 2 (H) receptor antagonists. J Immunol 1984; 132: 3054–3057
- Rocklin R. Histamine-induced suppressor factor (HSF): Effect on migration inhibitory factor (MIF) production and proliferation. J Immunol. 1977; 118: 1734–1738
- Claman H., Miller S., Sy M.-S., Moorhead J. Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev. 1980; 50: 105–132
- Miller S., Claman H. The induction of hapten-epecific Tcell tolerance by using hapten-modified lymphoid cells: I. Characteristics of tolerance induction. J Immunol. 1976; 117: 1519–1526
- Osband M., Shen Y.-J., Shlesinger M., Brown A., Hamilton D., Cohen E., Lavin P., McCaffrey R. Successful tumor immunotherapy with cimetidine in mice. Lancet 1981; 1: 636–638
- Gifford R., Ferguson R., Voss B. Cimetidine reduction of tumour formation in mice. Lancet 1981; 1: 638–640
- Cleveland R.P., Kumar A. Enhancement of anti-sheep erythrocyte plaque-forming cell levels by cimetidine in vivo. Immunopharm. 1987; 14: 145–150
- Borgstrom S., von Eyben F., Flodgren P., Axelsson B., Sjogren H. Human leukocyte interferon and cimetidine for metastatic melanoma. New Engl. J. Med. 1982; 307: 1080